Investment case

Leading the change

We are full life cycle investors supporting scientists and entrepreneurs at any stage where we identify opportunity, from academic programs in need of industry sponsorship all the way to mature publicly traded companies.

RTW financial highlights

As of 30 June 2022

US$265.7M

Ordinary NAV

20.1%

Ordinary NAV growth since Admission

-26.8%

Ordinary NAV per share growth YTD

US$7.6M

In cash/cash equivalents

excludes amounts due from brokers

US$1.25

NAV per Ordinary Share

-7.1%

Total shareholder return since Admission

-45.7%

Total shareholder return YTD

US$0.97

Price per Ordinary Share

the share price has since recovered to US$1.19 at 13 September 2022

RTW Venture Fund, Ltd.

RTW Venture Fund Ltd. is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Our approach is driven by applying deep scientific expertise with a long-term investment horizon.

We believe the companies best positioned to overcome these near-term challenges will be those who have chosen to focus on therapies for severe diseases with limited options and that also have meaningful commercial potential. 

Investment highlights

  • A closed-ended fund building and investing in biotech and medtech companies 
  • Provides access to private markets and bespoke negotiated opportunities
  • Managed by RTW Investments, LP, a seasoned healthcare investment firm 
  • Total Venture Fund shareholder return of +71.2% since 2019 IPO
  • Preferred capital provider to innovative companies with expertise in creative financial transactions
  • Extensive data collection of primary scientific data
  • Global reach

Executing our strategy

Maximizing value realization from transformative products takes time, and we believe it is critical to be involved and invested in such companies throughout various stages of their development and ultimately delivery to patients. In the instances where our research leads us to an innovation without a home inside an existing company, we have the capability, human power, and funding to create a company de novo to advance an asset we believe is worth building a business around.

Full lifecycle investing

We recognize the importance of providing growth capital along with the support of an experienced team, if and when it is needed, at any critical inflection point in an asset’s life cycle.

RTW Charitable Foundation

We created the RTW Charitable Foundation to pursue research into rare diseases with no commercial potential and to support humanitarian causes in our local communities. 

Explore

Fact sheets
Results, presentations, and research

Speak to a member of our team

This website is not intended to offer or to promote the offer or sale of the shares (the “shares”) of RTW Venture Fund Limited (the “company”) in the United States or to any “U.S. persons” as defined in regulation s (“US persons”) under the US Securities Act of 1933, as amended (the “securities act”). The materials contained herein are not for release, publication or distribution, directly or indirectly, in whole or in part, to any persons to whom or into or within any jurisdiction where to do so would constitute a violation of applicable law or regulation.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance. The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States or who are US Persons or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.